InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Vir Biotechnology, Inc.

VIR Clue Score34
United States Fiscal year ends December CIK 0001706431
$11.70 +5.22% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $11.70 −70.76% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 11 Oct 2019. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue2.7Operating income−81.5Net income−69.9Fiscal year 2018Revenue10.7 +293.9%Operating income−118.7Net income−115.9Fiscal year 2019Revenue8.1 −24.2%Operating income−178.0Net income−174.7EPS, diluted−5.76Fiscal year 2020Revenue76.4 +843.9%Operating income−297.0Net income−298.7EPS, diluted−2.51Fiscal year 2021Revenue1,095.4 +1,334.4%Operating income420.8Net income528.6EPS, diluted3.96Fiscal year 2022Revenue1,615.8 +47.5%Operating income833.1Net income515.8 −2.4%EPS, diluted3.83Fiscal year 2023Revenue86.2 −94.7%Operating income−684.3Net income−615.1 −219.2%EPS, diluted−4.59Fiscal year 2024Revenue74.2 −13.9%Operating income−587.2Net income−522.0EPS, diluted−3.83Fiscal year 2025Revenue68.6 −7.6%Operating income−479.3Net income−438.0EPS, diluted−3.16
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 2.7 10.7 8.1 76.4 1,095.4 1,615.8 86.2 74.2 68.6
Growth +293.9% −24.2% +843.9% +1,334.4% +47.5% −94.7% −13.9% −7.6%
Operating income −81.5 −118.7 −178.0 −297.0 420.8 833.1 −684.3 −587.2 −479.3
Net income −69.9 −115.9 −174.7 −298.7 528.6 515.8 −615.1 −522.0 −438.0
Growth −2.4% −219.2%
EPS, diluted n/a n/a −5.76 −2.51 3.96 3.83 −4.59 −3.83 −3.16

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Operating margin−3,009.5%Net margin−2,579.5%Free cash flow margin−2,552.5%Fiscal year 2018Operating margin−1,112.6%Net margin−1,086.3%Free cash flow margin−958.8%Fiscal year 2019Operating margin−2,199.7%Net margin−2,159.0%Free cash flow margin−1,712.7%Fiscal year 2020Operating margin−388.9%Net margin−391.1%Free cash flow margin−258.6%Fiscal year 2021Operating margin38.4%Net margin48.3%Free cash flow margin−6.3%Fiscal year 2022Operating margin51.6%Net margin31.9%Free cash flow margin98.7%Fiscal year 2023Operating margin−794.0%Net margin−713.7%Free cash flow margin−928.7%Fiscal year 2024Operating margin−791.3%Net margin−703.4%Free cash flow margin−611.4%Fiscal year 2025Operating margin−699.2%Net margin−638.9%Free cash flow margin−578.5%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −3,009.5% −1,112.6% −2,199.7% −388.9% 38.4% 51.6% −794.0% −791.3% −699.2%
Net margin −2,579.5% −1,086.3% −2,159.0% −391.1% 48.3% 31.9% −713.7% −703.4% −638.9%
Free cash flow margin −2,552.5% −958.8% −1,712.7% −258.6% −6.3% 98.7% −928.7% −611.4% −578.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−66.4Capital expenditure−2.7Free cash flow−69.1Fiscal year 2018Operating cash flow−94.1Capital expenditure−8.2Free cash flow−102.3Fiscal year 2019Operating cash flow−129.6Capital expenditure−8.9Free cash flow−138.6Fiscal year 2020Operating cash flow−190.9Capital expenditure−6.5Free cash flow−197.5Fiscal year 2021Operating cash flow−47.6Capital expenditure−21.8Free cash flow−69.4Fiscal year 2022Operating cash flow1,663.3Capital expenditure−68.0Free cash flow1,595.2Fiscal year 2023Operating cash flow−778.8Capital expenditure−21.6Free cash flow−800.4 −150.2%Fiscal year 2024Operating cash flow−446.4Capital expenditure−7.3Free cash flow−453.7Fiscal year 2025Operating cash flow−391.8Capital expenditure−4.8Free cash flow−396.6
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −66.4 −94.1 −129.6 −190.9 −47.6 1,663.3 −778.8 −446.4 −391.8
Capital expenditure −2.7 −8.2 −8.9 −6.5 −21.8 −68.0 −21.6 −7.3 −4.8
Free cash flow −69.1 −102.3 −138.6 −197.5 −69.4 1,595.2 −800.4 −453.7 −396.6
Growth −150.2%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Cash187.9Shareholders’ equity−68.9Fiscal year 2018Cash47.6Shareholders’ equity−179.2Fiscal year 2019Cash109.3Shareholders’ equity423.9Fiscal year 2020Cash436.6Shareholders’ equity716.9Fiscal year 2021Cash347.8Shareholders’ equity1,431.8Fiscal year 2022Cash848.6Shareholders’ equity2,078.0Fiscal year 2023Cash241.6Shareholders’ equity1,590.2Fiscal year 2024Cash222.9Shareholders’ equity1,150.4Fiscal year 2025Cash232.2Shareholders’ equity765.3
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 187.9 47.6 109.3 436.6 347.8 848.6 241.6 222.9 232.2
Shareholders’ equity −68.9 −179.2 423.9 716.9 1,431.8 2,078.0 1,590.2 1,150.4 765.3

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
2.7 10.7 8.1 76.4 1,095.4 1,615.8 86.2 74.2 68.6
Growth +293.9% −24.2% +843.9% +1,334.4% +47.5% −94.7% −13.9% −7.6%
n/a n/a 0.0 0.0 65.9 146.3 2.8 0.8 0.0
62.5 100.2 148.5 302.4 448.0 474.6 579.7 506.5 456.0
21.7 29.1 37.6 70.9 160.8 161.8 174.4 119.0 92.1
−81.5 −118.7 −178.0 −297.0 420.8 833.1 −684.3 −587.2 −479.3
Growth +98.0% −182.1%
−80.8 −116.4 −174.5 −298.6 549.8 754.3 −628.2 −523.1 −437.8
−10.9 −0.5 0.2 0.1 21.2 238.4 −13.1 −1.1 0.2
−69.9 −115.9 −174.7 −298.7 528.6 515.8 −615.1 −522.0 −438.0
Growth −2.4% −219.2%
Per share
n/a n/a −5.76 −2.51 4.07 3.89 −4.59 −3.83 −3.16
n/a n/a −5.76 −2.51 3.96 3.83 −4.59 −3.83 −3.16
Growth −3.3% −219.8%
n/a n/a 30.3 119.2 129.9 132.6 134.1 136.2 138.5
n/a n/a 30.3 119.2 133.4 134.8 134.1 136.2 138.5
Growth +292.6% +12.0% +1.0% −0.5% +1.6% +1.7%

† The diluted share count jumps at 2020, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 2.1% a year over five years.
  • Operating margin is down 310.3 points on five years ago, at -699.2%.
  • A net loss in 7 of 9 years on file.